Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway

Zhou,Yanyun; Zhang,Hong; Huang,Yitong; Wu,Shengyun; Liu,Zongjun

doi:10.3892/mmr.2022.12844

Tanshinone IIA regulates expression of glucose transporter 1 via activation of the HIF‑1α signaling pathway

Authors:
- Yanyun Zhou
- Hong Zhang
- Yitong Huang
- Shengyun Wu
- Zongjun Liu
View Affiliations

Affiliations: Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China, Department of Cardiovascular Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China
Published online on: September 6, 2022 https://doi.org/10.3892/mmr.2022.12844
Article Number: 328
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tanshinone IIA (Tan 2A) is a lipid‑soluble compound extracted from the Chinese herb Danshen (Salvia miltiorrhiza Bunge). It protects neuron and microvascular endothelial cells against hypoxia/ischemia both in vitro and in vivo however the mechanism is not fully known. Glucose transporter 1 (GLUT‑1) is ubiquitously expressed in all types of tissue in the human body and serves important physiological functions due to its glucose uptake ability. The present study evaluated the role of Tan 2A in regulating GLUT‑1 expression and its potential mechanism. RT‑PCR and western Blot were used to detect the expression of GLUT‑1. Si RNA mediated knockdown and CHIP assay were used to explore the mechanism of Tan 2A on GLUT‑1expression. Tan 2A treatment induced expression of GLUT‑1 and subsequently increased glucose uptake in endothelial cells (ECs). Furthermore, mRNA expression levels of vascular endothelial cell growth factor, BCL2 interacting protein 3 and enolase 2, which are target genes for hypoxia‑inducible factor‑1α (HIF‑1α), were significantly upregulated by Tan 2A. Co‑immunoprecipitation demonstrated that Tan 2A markedly increased the association of HIF‑1α with recombination signal‑binding protein for immunoglobulin κJ region (RBPJκ). Moreover, knockdown of HIF‑1α and RBPJκ significantly reversed the regulatory effect of Tan 2A on mRNA expression levels of these genes in ECs. The results of the present study suggested that HIF‑1α partially mediated the regulatory effect of Tan 2A on GLUT‑1 expression in ECs. Therefore, GLUT‑1 may be a potential therapeutic target for Tan 2A.

View Figures

View References

1	Mergenthaler P, Lindauer U, Dienel GA and Meisel A: Sugar for the brain: The role of glucose in physiological and pathological brain function. Trends Neurosci. 36:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
2	Zhao FQ and Keating AF: Functional properties and genomics of glucose transporters. Curr Genomics. 8:113–128. 2007. View Article : Google Scholar : PubMed/NCBI
3	Kayano T, Fukumoto H, Eddy RL, Fan YS, Byers MG, Shows TB and Bell GI: Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J Biol Chem. 263:15245–15248. 1988. View Article : Google Scholar : PubMed/NCBI
4	Mueckler M: Facilitative glucose transporters. Eur J Biochem. 219:713–725. 1994. View Article : Google Scholar : PubMed/NCBI
5	Veys K, Fan Z, Ghobrial M, Bouche A, Garcia-Caballero M, Vriens K, Conchinha NV, Seuwen A, Schlegel F and Gorski T: Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood-brain barrier integrity. Circ Res. 127:466–482. 2020. View Article : Google Scholar : PubMed/NCBI
6	Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE and Bell GI: Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. J Biol Chem. 267:467–472. 1992. View Article : Google Scholar : PubMed/NCBI
7	Wang H, Pang W, Xu X, You B, Zhang C and Li D: Cryptotanshinone attenuates ischemia/reperfusion-induced apoptosis in myocardium by upregulating MAPK3. J Cardiovasc Pharmacol. 77:370–377. 2021. View Article : Google Scholar : PubMed/NCBI
8	Xu J, Zhang P, Chen Y, Xu Y, Luan P, Zhu Y and Zhang J: Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis. Exp Ther Med. 22:11222021. View Article : Google Scholar : PubMed/NCBI
9	Subedi L and Gaire BP: Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res. 169:1056612021. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Li C, Meng H, Guo D, Zhang Q, Lu W, Wang Q, Wang Y and Tu P: BYD ameliorates oxidative stress-induced myocardial apoptosis in heart failure post-acute myocardial infarction via the P38 MAPK-CRYAB signaling pathway. Front Physiol. 9:5052018. View Article : Google Scholar : PubMed/NCBI
11	Tang Q, Han R, Xiao H, Shen J, Luo Q and Li J: Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro. Brain Res. 1488:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
12	Zhu J, Xu Y, Ren G, Hu X, Wang C, Yang Z, Li Z, Mao W and Lu D: Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 815:427–436. 2017. View Article : Google Scholar : PubMed/NCBI
13	Lou G, Hu W, Wu Z, Xu H, Yao H, Wang Y, Huang Q, Wang B, Wen L, Gong D, et al: Tanshinone II A attenuates vascular remodeling through klf4 mediated smooth muscle cell phenotypic switching. Sci Rep. 10:138582020. View Article : Google Scholar : PubMed/NCBI
14	Chen W, Li X, Guo S, Song N, Wang J, Jia L and Zhu A: Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis. Int Immunopharmacol. 70:486–497. 2019. View Article : Google Scholar : PubMed/NCBI
15	Xie Z, Truong TL, Zhang P, Xu F, Xu X and Li P: Dan-Qi prescription ameliorates insulin resistance through overall corrective regulation of glucose and fat metabolism. J Ethnopharmacol. 172:70–79. 2015. View Article : Google Scholar : PubMed/NCBI
16	Guan R, Wang J, Li Z, Ding M, Li D, Xu G, Wang T, Chen Y, Yang Q, Long Z, et al: Sodium tanshinone IIA sulfonate decreases cigarette smoke-induced inflammation and oxidative stress via blocking the activation of MAPK/HIF-1alpha signaling pathway. Front Pharmacol. 9:2632018. View Article : Google Scholar : PubMed/NCBI
17	Zhou L, Sui H, Wang T, Jia R, Zhang Z, Fu J, Feng Y, Liu N, Ji Q, Wang Y, et al: Tanshinone IIA reduces secretion of proangiogenic factors and inhibits angiogenesis in human colorectal cancer. Oncol Rep. 43:1159–1168. 2020.PubMed/NCBI
18	Zhou ZY, Zhao WR, Xiao Y, Zhang J, Tang JY and Lee SM: Mechanism study of the protective effects of sodium tanshinone IIA sulfonate against atorvastatin-induced cerebral hemorrhage in zebrafish: Transcriptome analysis. Front Pharmacol. 11:5517452020. View Article : Google Scholar : PubMed/NCBI
19	Fu P, Du F, Chen W, Yao M, Lv K and Liu Y: Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1alpha downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines. Oncol Rep. 31:2561–2568. 2014. View Article : Google Scholar : PubMed/NCBI
20	Xu M, Cao F, Liu L, Zhang B, Wang Y, Dong H, Cui Y, Dong M, Xu D, Liu Y, et al: Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression. Am J Respir Cell Mol Biol. 45:1028–1035. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lu Y, Wang SJ and Song XT: Effects of electroacupuncture on glucose transporter-1 expression of hippocampal microvascular endothelial cells in rats with focal cerebral ischemia. Zhen Ci Yan Jiu. 35:118–123. 2010.(In Chinese). PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Wang Y, Zhang Y, Zhu Y and Zhang P: Lipolytic inhibitor G0/G1 switch gene 2 inhibits reactive oxygen species production and apoptosis in endothelial cells. Am J Physiol Cell Physiol. 308:C496–C504. 2015. View Article : Google Scholar : PubMed/NCBI
24	Baudin B, Bruneel A, Bosselut N and Vaubourdolle M: A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2:481–485. 2007. View Article : Google Scholar : PubMed/NCBI
25	Masson N and Ratcliffe PJ: HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci. 116:3041–3049. 2003. View Article : Google Scholar : PubMed/NCBI
26	Wang Y, Singh AR, Zhao Y, Du T, Huang Y, Wan X, Mukhopadhyay D, Wang Y, Wang N and Zhang P: TRIM28 regulates sprouting angiogenesis through VEGFR-DLL4-notch signaling circuit. FASEB J. 34:14710–14724. 2020. View Article : Google Scholar : PubMed/NCBI
27	Diaz-Trelles R, Scimia MC, Bushway P, Tran D, Monosov A, Monosov E, Peterson K, Rentschler S, Cabrales P, Ruiz-Lozano P and Mercola M: Notch-independent RBPJ controls angiogenesis in the adult heart. Nat Commun. 7:120882016. View Article : Google Scholar : PubMed/NCBI
28	Benarroch EE: Brain glucose transporters: Implications for neurologic disease. Neurology. 82:1374–1379. 2014. View Article : Google Scholar : PubMed/NCBI
29	Szablewski L: Brain glucose transporters: Role in pathogenesis and potential targets for the treatment of Alzheimer's disease. Int J Mol Sci. 22:81422021. View Article : Google Scholar : PubMed/NCBI
30	Allen A and Messier C: Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice. Behav Brain Res. 240:95–102. 2013. View Article : Google Scholar : PubMed/NCBI
31	Choeiri C, Staines W, Miki T, Seino S and Messier C: Glucose transporter plasticity during memory processing. Neuroscience. 130:591–600. 2005. View Article : Google Scholar : PubMed/NCBI
32	Simpson IA, Carruthers A and Vannucci SJ: Supply and demand in cerebral energy metabolism: The role of nutrient transporters. J Cereb Blood Flow Metab. 27:1766–1791. 2007. View Article : Google Scholar : PubMed/NCBI
33	Ullner PM, Di Nardo A, Goldman JE, Schobel S, Yang H, Engelstad K, Wang D, Sahin M and Vivo DCD: Murine Glut-1 transporter haploinsufficiency: Postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis. 36:60–69. 2009. View Article : Google Scholar : PubMed/NCBI
34	Zlokovic BV: Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 12:723–738. 2011. View Article : Google Scholar : PubMed/NCBI
35	Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, et al: GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 18:521–530. 2015. View Article : Google Scholar : PubMed/NCBI
36	Park JL, Heilig CW and Brosius FC III: GLUT1-deficient mice exhibit impaired endothelium-dependent vascular relaxation. Eur J Pharmacol. 496:213–214. 2004. View Article : Google Scholar : PubMed/NCBI
37	Gao S, Liu Z, Li H, Little PJ, Liu PA and Xu S: Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 220:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
38	Xu S and Liu P: Tanshinone II-A: New perspectives for old remedies. Expert Opin Ther Pat. 23:149–153. 2013. View Article : Google Scholar : PubMed/NCBI
39	Sun D, Shen M, Li J, Li W, Zhang Y, Zhao L, Zhang Z, Yuan Y, Wang H and Cao F: Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol. 10:42011. View Article : Google Scholar : PubMed/NCBI
40	Pan C, Lou L, Huo Y, Singh G, Chen M, Zhang D, Wu A, Zhao M, Wang S and Li J: Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Ther Adv Cardiovasc Dis. 5:99–111. 2011. View Article : Google Scholar : PubMed/NCBI
41	Yang R, Liu A, Ma X, Li L, Su D and Liu J: Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol. 51:396–401. 2008. View Article : Google Scholar : PubMed/NCBI
42	Wang J, Tong H, Wang X, Wang X and Wang Y: Tanshinone IIA alleviates the damage of neurocytes by targeting GLUT1 in ischaemia reperfusion model (in vivo and in vitro experiments). Folia Neuropathol. 58:176–193. 2020. View Article : Google Scholar : PubMed/NCBI
43	Nanayakkara G, Alasmari A, Mouli S, Eldoumani H, Quindry J, McGinnis G, Fu X, Berlin A, Peters B, Zhong J and Amin R: Cardioprotective HIF-1alpha-frataxin signaling against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 309:H867–H879. 2015. View Article : Google Scholar : PubMed/NCBI
44	Ahn GO, Seita J, Hong BJ, Kim YE, Bok S, Lee CJ, Kim KS, Lee JC, Leeper NJ, Cooke JP, et al: Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci USA. 111:2698–2703. 2014. View Article : Google Scholar : PubMed/NCBI
45	Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC and Pouysségur J: Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69:358–368. 2009. View Article : Google Scholar : PubMed/NCBI
46	Dungwa JV, Hunt LP and Ramani P: Overexpression of carbonic anhydrase and HIF-1α in wilms tumours. BMC Cancer. 11:3902011. View Article : Google Scholar : PubMed/NCBI
47	Yang R, Lu Y and Liu J: Identification of tanshinone IIA as a natural monoacylglycerol lipase inhibitor by combined in silico and in vitro approach. MedChemComm. 5:1528–1532. 2014. View Article : Google Scholar
48	Zeng L, Wu Q, Wang T, Li LP, Zhao X, Chen K, Qian J, Yuan L, Xu H and Mei WJ: Selective stabilization of multiple promoter G-quadruplex DNA by using 2-phenyl-1H-imidazole-based tanshinone IIA derivatives and their potential suppressing function in the metastatic breast cancer. Bioorg Chem. 106:1044332021. View Article : Google Scholar : PubMed/NCBI
49	Zhang L, Zhu C, Guo Y, Wei F, Lu J, Qin J, Banerjee S, Wang J, Shang H, Verma SC, et al: Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. J Virol. 88:6873–6884. 2014. View Article : Google Scholar : PubMed/NCBI
50	Hu YY, Fu LA, Li SZ, Chen Y, Li JC, Han J, Liang L, Li L, Ji CC, Zheng MH and Hdan H: Hif-1alpha and Hif-2alpha differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells. Cancer Lett. 349:67–76. 2014. View Article : Google Scholar : PubMed/NCBI
51	Lakhan R and Rathinam CV: Deficiency of Rbpj leads to defective stress-induced hematopoietic stem cell functions and hif mediated activation of non-canonical notch signaling pathways. Front Cell Dev Biol. 8:6221902020. View Article : Google Scholar : PubMed/NCBI